Benefit Versus Risk Assessment of Melflufen and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Analyses From Longer Follow-up of the OCEAN and HORIZON Studies
Titel:
Benefit Versus Risk Assessment of Melflufen and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Analyses From Longer Follow-up of the OCEAN and HORIZON Studies
Auteur:
Sonneveld, Pieter Richardson, Paul G. Ludwig, Heinz Dimopoulos, Meletios-Athanasios Schjesvold, Fredrik H. Hájek, Roman Abdulhaq, Haifaa Thuresson, Marcus Norin, Stefan Bakker, Nicolaas A. Mateos, Maria-Victoria